GlycoNet researchers have made exciting advances in understanding Alzheimer’s disease and are developing a potential therapeutic strategy.
Category: Research Highlight
GlycoNet researchers studying complex enzymes gain insight into how some pathogens could potentially be targeted without antibiotics.
Understanding the process could help scientists look out for new, more infectious variants, say GlycoNet researchers.
A natural compound that slows the breakdown of starch could be used to develop a more pleasant treatment for managing Type 2 diabetes.
Knowledge in the sugars that coat blood vessels helps researchers find a way to reduce organ rejection.
GlycoNet Investigators study the sugars on red blood cells to find ways to make universal donor blood
A GlycoCage technology developed by GlycoNet researchers aims to improve current treatments for inflammatory bowel disease
Research highlights potential pathway for new treatments for neurodegenerative diseases
Professor and GlycoNet Investigator Simonetta Sipione’s research awarded major grant from the Canadian Institutes of Health Research
Nuclear medicine researcher and GlycoNet Investigator Chris Phenix from the University of Saskatchewan has been awarded US$150,000 by The Michael J. Fox Foundation to develop diagnostic radiotracers for early detection of Parkinson’s Disease